Great West Life Assurance CO Editas Medicine, Inc. Transaction History

Great West Life Assurance CO

  • $53.1 Billion
  • Q2 2024

A detailed history of Great West Life Assurance CO transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 20,077 shares of EDIT stock, worth $79,304. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,077
Previous 43,508 53.85%
Holding current value
$79,304
Previous $322,000 71.12%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$4.67 - $7.28 $109,422 - $170,577
-23,431 Reduced 53.85%
20,077 $93,000
Q1 2024

May 13, 2024
BUY
$7.03 - $11.07 $11,831 - $18,630
1,683 Added 4.02%
43,508 $322,000
Q4 2023

Feb 13, 2024
BUY
$6.25 - $11.11 $138,737 - $246,619
22,198 Added 113.1%
41,825 $421,000
Q3 2023

Nov 14, 2023
BUY
$6.92 - $9.31 $50,543 - $68,000
7,304 Added 59.27%
19,627 $153,000
Q2 2023

Aug 10, 2023
BUY
$6.36 - $11.47 $17,369 - $31,324
2,731 Added 28.47%
12,323 $101,000
Q1 2023

May 12, 2023
BUY
$7.03 - $11.53 $37,701 - $61,835
5,363 Added 126.81%
9,592 $69,000
Q4 2022

Feb 10, 2023
BUY
$8.32 - $13.21 $1,971 - $3,130
237 Added 5.94%
4,229 $38,000
Q3 2022

Nov 01, 2022
BUY
$12.16 - $19.42 $48,542 - $77,524
3,992 New
3,992 $48,000
Q2 2022

Aug 09, 2022
BUY
$9.99 - $21.35 $1,478 - $3,159
148 Added 3.99%
3,857 $46,000
Q1 2022

May 12, 2022
BUY
$14.08 - $27.63 $1,703 - $3,343
121 Added 3.37%
3,709 $75,000
Q4 2021

Feb 14, 2022
BUY
$26.55 - $40.57 $3,026 - $4,624
114 Added 3.28%
3,588 $95,000
Q2 2021

Aug 11, 2021
SELL
$31.29 - $56.64 $21,683 - $39,251
-693 Reduced 16.63%
3,474 $197,000
Q3 2020

Nov 17, 2020
SELL
$28.06 - $37.16 $201,049 - $266,251
-7,165 Reduced 63.23%
4,167 $116,000
Q3 2020

Nov 13, 2020
BUY
$28.06 - $37.16 $201,049 - $266,251
7,165 Added 171.95%
11,332 $317,000
Q2 2020

Aug 17, 2020
BUY
$18.5 - $34.34 $22,144 - $41,104
1,197 Added 40.3%
4,167 $123,000
Q4 2019

Feb 11, 2020
BUY
$19.49 - $32.63 $29,546 - $49,467
1,516 Added 104.26%
2,970 $87,000
Q3 2019

Oct 25, 2019
SELL
$22.49 - $26.81 $88,430 - $105,416
-3,932 Reduced 73.0%
1,454 $33,000
Q2 2019

Jul 31, 2019
BUY
$20.48 - $27.76 $20,152 - $27,315
984 Added 22.35%
5,386 $0
Q4 2018

Feb 12, 2019
SELL
$18.19 - $31.79 $407,692 - $712,509
-22,413 Reduced 83.58%
4,402 $97,000
Q3 2018

Nov 13, 2018
SELL
$27.65 - $38.39 $725,536 - $1.01 Million
-26,240 Reduced 49.46%
26,815 $856,000
Q2 2018

Aug 10, 2018
BUY
$31.4 - $41.01 $102,018 - $133,241
3,249 Added 6.52%
53,055 $1.9 Million
Q1 2018

May 10, 2018
BUY
$29.84 - $44.08 $1.34 Million - $1.98 Million
44,847 Added 904.36%
49,806 $1.65 Million
Q3 2017

Nov 09, 2017
BUY
$15.81 - $24.01 $78,401 - $119,065
4,959
4,959 $114,000

Others Institutions Holding EDIT

# of Institutions
252
Shares Held
58.7M
Call Options Held
494K
Put Options Held
417K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $272M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email